These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 6728042)
1. 2-[125Iodo]LSD, a new ligand for the characterisation and localisation of 5-HT2 receptors. Engel G; Müller-Schweinitzer E; Palacios JM Naunyn Schmiedebergs Arch Pharmacol; 1984 Apr; 325(4):328-36. PubMed ID: 6728042 [TBL] [Abstract][Full Text] [Related]
2. Identification of 5HT2-receptors on longitudinal muscle of the guinea pig ileum. Engel G; Hoyer D; Kalkman HO; Wick MB J Recept Res; 1984; 4(1-6):113-26. PubMed ID: 6527351 [TBL] [Abstract][Full Text] [Related]
3. Evidence for mediation by 5-HT2 receptors of 5-hydroxytryptamine-induced contraction of canine basilar artery. Müller-Schweinitzer E; Engel G Naunyn Schmiedebergs Arch Pharmacol; 1983 Dec; 324(4):287-92. PubMed ID: 6664382 [TBL] [Abstract][Full Text] [Related]
4. Localization and characterization by quantitative autoradiography of [125I]LSD binding sites in rat brain. Nakada MT; Wieczorek CM; Rainbow TC Neurosci Lett; 1984 Aug; 49(1-2):13-8. PubMed ID: 6493586 [TBL] [Abstract][Full Text] [Related]
5. Autoradiographic characterization of (+-)-1-(2,5-dimethoxy-4-[125I] iodophenyl)-2-aminopropane ([125I]DOI) binding to 5-HT2 and 5-HT1c receptors in rat brain. Appel NM; Mitchell WM; Garlick RK; Glennon RA; Teitler M; De Souza EB J Pharmacol Exp Ther; 1990 Nov; 255(2):843-57. PubMed ID: 2243353 [TBL] [Abstract][Full Text] [Related]
6. Characterization of 125I-lysergic acid diethylamide binding to serotonin receptors in rat frontal cortex. Kadan MJ; Krohn AM; Evans MJ; Waltz RL; Hartig PR J Neurochem; 1984 Sep; 43(3):601-6. PubMed ID: 6747625 [TBL] [Abstract][Full Text] [Related]
7. Detection of 5-hydroxytryptamine2 receptors by radioligand binding, northern blot analysis, and Ca2+ responses in rat primary astrocyte cultures. Deecher DC; Wilcox BD; Dave V; Rossman PA; Kimelberg HK J Neurosci Res; 1993 Jun; 35(3):246-56. PubMed ID: 8394435 [TBL] [Abstract][Full Text] [Related]
8. Autoradiographic comparison of [125I]LSD-labeled 5-HT2A receptor distribution in rat and guinea pig brain. Watts SW; Gackenheimer SL; Gehlert DR; Cohen ML Neurochem Int; 1994 Jun; 24(6):565-74. PubMed ID: 7981639 [TBL] [Abstract][Full Text] [Related]
9. Binding sites for 5-hydroxytryptamine-2 receptor agonists are predominantly located in striosomes in the human basal ganglia. Waeber C; Palacios JM Brain Res Mol Brain Res; 1994 Jul; 24(1-4):199-209. PubMed ID: 7968358 [TBL] [Abstract][Full Text] [Related]
10. [125I]LSD labels 5-HT1C recognition sites in pig choroid plexus membranes. Comparison with [3H]mesulergine and [3H]5-HT binding. Hoyer D; Srivatsa S; Pazos A; Engel G; Palacios JM Neurosci Lett; 1986 Sep; 69(3):269-74. PubMed ID: 3763057 [TBL] [Abstract][Full Text] [Related]
11. N1-methyl-2-125I-lysergic acid diethylamide, a preferred ligand for in vitro and in vivo characterization of serotonin receptors. Hoffman BJ; Scheffel U; Lever JR; Karpa MD; Hartig PR J Neurochem; 1987 Jan; 48(1):115-24. PubMed ID: 3794694 [TBL] [Abstract][Full Text] [Related]
12. Autoradiographic localization of 5-HT1 receptors to human and canine basilar arteries. Peroutka SJ; Kuhar MJ Brain Res; 1984 Sep; 310(1):193-6. PubMed ID: 6478239 [TBL] [Abstract][Full Text] [Related]
13. Unsurmountable antagonism of brain 5-hydroxytryptamine2 receptors by (+)-lysergic acid diethylamide and bromo-lysergic acid diethylamide. Burris KD; Sanders-Bush E Mol Pharmacol; 1992 Nov; 42(5):826-30. PubMed ID: 1359397 [TBL] [Abstract][Full Text] [Related]
14. The interaction of RS 25259-197, a potent and selective antagonist, with 5-HT3 receptors, in vitro. Wong EH; Clark R; Leung E; Loury D; Bonhaus DW; Jakeman L; Parnes H; Whiting RL; Eglen RM Br J Pharmacol; 1995 Feb; 114(4):851-9. PubMed ID: 7773546 [TBL] [Abstract][Full Text] [Related]
15. 125I-LSD autoradiography confirms the preferential localization of caudate-putamen S2 receptors to the caudal (peripallidal) region. Altar CA; Boyar WC; Marien MR Brain Res; 1986 Apr; 372(1):130-6. PubMed ID: 2423187 [TBL] [Abstract][Full Text] [Related]
16. Autoradiographic localization of 5HT2 receptors in rat brain using [125I]-DOI, a selective psychotomimetic radioligand. Nazarali AJ; McKenna DJ; Saavedra JM Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(3-4):573-81. PubMed ID: 2748882 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of [125I]-(S)-iodozacopride, a high affinity radioligand for 5HT3 receptors. Gehlert DR; Schober DA; Gackenheimer SL; Mais DE; Ladouceur G; Robertson DW Neurochem Int; 1993 Oct; 23(4):373-83. PubMed ID: 8220179 [TBL] [Abstract][Full Text] [Related]
18. Relationship between receptors mediating serotonin (5-HT) contractions in the canine basilar artery to 5-HT1, 5-HT2 and rat stomach fundus 5-HT receptors. Cohen ML; Colbert WE J Pharmacol Exp Ther; 1986 Jun; 237(3):713-8. PubMed ID: 3712277 [TBL] [Abstract][Full Text] [Related]
19. Multiple serotonin receptors: regional distribution and effect of Raphe lesions. Blackshear MA; Steranka LR; Sanders-Bush E Eur J Pharmacol; 1981 Dec; 76(4):325-34. PubMed ID: 7327207 [TBL] [Abstract][Full Text] [Related]
20. (+)Lysergic acid diethylamide, but not its nonhallucinogenic congeners, is a potent serotonin 5HT1C receptor agonist. Burris KD; Breeding M; Sanders-Bush E J Pharmacol Exp Ther; 1991 Sep; 258(3):891-6. PubMed ID: 1679849 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]